JONES STEVEN C 4
4 · NEOGENOMICS INC · Filed Dec 7, 2020
Insider Transaction Report
Form 4
JONES STEVEN C
DirectorExecutive VP of Finance10% Owner
Transactions
- Sale
Common Stock
2020-12-03$48.03/sh−19,948$958,102→ 1,180,052 total(indirect: By Aspen Select Opportunity Fund) - Sale
Common Stock
2020-12-04$48.07/sh−64,394$3,095,420→ 1,115,658 total(indirect: By Aspen Select Opportunity Fund) - Sale
Common Stock
2020-12-07$49.45/sh−45,658$2,257,788→ 1,070,000 total(indirect: By Aspen Select Opportunity Fund)
Holdings
- 30,476(indirect: By Jones Network, LP)
Common Stock
- 125,000(indirect: By Trust)
Common Stock
- 40,757(indirect: By Trust)
Common Stock
- 72,932
Common Stock
- 100,000(indirect: By Aspen Select Opportunity Fund)
Stock Option (Right to Buy)
Exercise: $7.15Exp: 2021-04-20→ Common Stock (100,000 underlying) - 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,448
Stock Option (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
- [F2]On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP.
- [F3]On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.